Erik Holzwanger, MD
Gastroenterology · Boston, MANPI 1457747776
Payments from drug & device makers
Across 92 payments — averaging $1004.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$79K
- Micro-tech Endoscopy USA, Inc.$8K
- Olympus Medical Systems Corporation$4K
- Cook Medical LLC$356
- Fujifilm Healthcare Americas Corporation$209
- Medtronic$188
- plus $503 from 5 others
What the payments were for
- Consulting fees$17,11519%
- Speaking & faculty fees$21,05023%
- Grants$50,00054%
- Travel & lodging$3510%
- Food & beverage$3,7644%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 61 | $79,266 |
| Micro-tech Endoscopy USA, Inc. | 5 | $7,556 |
| Olympus Medical Systems Corporation | 4 | $4,302 |
| Cook Medical LLC | 3 | $356 |
| Fujifilm Healthcare Americas Corporation | 2 | $209 |
| Medtronic | 5 | $188 |
| Apollo Endosurgery US Inc | 4 | $179 |
| Johnson & Johnson | 4 | $153 |
| Conmed Corporation | 1 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $60 |
| Bristol Myers Squibb | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$30,500
- OverStitch Endoscopic Suturing System$5,500
- EXALT Model D$5,168
- EVIS EXERA III COLONOVIDEOSCOPE$2,200
- GASTROINTESTINAL VIDEOSCOPE$2,065
- AXIOS$435
- APOLLO ESG System$138
- ECHOTIP INSIGHT$132
- FUSION$131
- FUJIFILM$124
How this compares
$92,379 in reported general payments places this provider in the 85th percentile of 579 gastroenterology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 11 | $13,025 |
| LinzessLinaclotide | 11 | $5,376 |
| Sucralfate | 22 | $2,341 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 86 | $1,341 |
| Colestipol Hcl | 12 | $932 |
| Omeprazole | 49 | $893 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 34 | $596 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $399 |
| Nortriptyline Hcl | 27 | $196 |
| Ciprofloxacin Hcl | 15 | $55 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Boston
- Ramnik XavierBoston$14.3M
- Scott SnapperBoston$4.9M
- Jessica AllegrettiBoston$3.3M
- John LeungBoston$2.8M
- Michael DouganBoston$2M
- Raymond ChungBoston$1.4M
- Kathleen CoreyBoston$1.4M
- Joshua KorzenikBoston$1.2M
- Hiroyuki AiharaBoston$988K
- Carlo TraversoBoston$987K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.